Jinsong Wu
Huashan Hospital · Huashan Hospital Shanghai
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Jinsong Wu as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 13:04 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT07912398 · HMPL-306 in Participants With Postoperative Residual or Recurrent Grade 2 Glioma Harboring IDH1 or IDH2 MutationsHutchmed · not yet recruiting · Grade 2 Astrocytoma or Oligodendroglioma With an IDH1 or IDH2 Mutation · principal investigator
- Ph1NCT07025018 · Phase I Study of HMPL-306 for the Treatment of Gliomas With IDH1 and/or IDH2 MutationsHutchmed · recruiting · Gliomas Harboring IDH1 and/or IDH2 Mutations · principal investigator
- N/ANCT05486923 · Validity and Reliability Evaluation of the PRO-CTCAE for Adult-type Diffuse Gliomas Patients in Chinese PopulationHuashan Hospital · completed · Glioma, Patient Reported Outcome Measures, Self Report · study chair
- Ph1NCT05388487 · Tolerability and Safety of HF1K16 Injection in Patients With Refractory Solid TumorsHighField Biopharmaceuticals Corporation · unknown · Solid Tumor, Adult · principal investigator
- N/ANCT05300113 · Artificial Intelligence NeuropathologistHuashan Hospital · unknown · CNS Tumor, Neuropathology · study chair
- N/ANCT03974659 · Enhanced Recovery After Surgery Using TMS on Cerebellar Language Area for Brain Tumor PatientsHuashan Hospital · unknown · Cerebellar Function, Transcranial Magnetic Stimulation, Language Disorders · principal investigator
- N/ANCT03641391 · Awake Intraoperative Language Mapping and Chinese Probabilistic Map ConstructionHuashan Hospital · unknown · Glioma · principal investigator
- N/ANCT03631823 · Gut Microbiota and Glioblastoma Multiforme PrognosisHuashan Hospital · unknown · Gut Microbiota, Glioblastoma Multiforme, Microglia, Tumor Related Macrophagocyte, Prognosis · study chair
- N/ANCT03152708 · CAN008 Biomarker CD95 Ligand and CpG2 Methylation in Chinese Patients With GlioblastomaCANbridge Life Sciences Ltd. · unknown · Glioblastoma · principal investigator
- N/ANCT02795364 · Study About the Validity of MRS-guided Resection on Prognosis High-grade Glioma GliomasHuashan Hospital · unknown · Glioma, Anaplastic Oligoastrocytoma, Glioblastomas (GBM) · principal investigator
- Ph2NCT02209428 · A Prospective Cohort to Study the Effect of Temozolomide on IDH Mutational Low Grade GliomasHuashan Hospital · unknown · Astrocytoma, Oligodendroglioma, Oligoastrocytoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 13:04 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name in glioma, ranked by citations from NIH iCite, fetched 2026-11-12 13:04 UTC. The ranking covers the 200 most relevant of 25 PubMed records, and a shared surname and initials can bring in a namesake. All 25 on PubMed
- 635 citationsRCR 18.4
- First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma.J Transl Med · 2018426 citationsRCR 14.6
- 417 citationsRCR 37.4
- 242 citationsRCR 8.0
- Everolimus for subependymal giant cell astrocytoma in patients with tuberous sclerosis complex: 2-year open-label extension of the randomised EXIST-1 study.Lancet Oncol · 2014141 citationsRCR 4.1
- Phase 0 Trial of AZD1775 in First-Recurrence Glioblastoma Patients.Clin Cancer Res · 201875 citationsRCR 2.5
- The effect of everolimus on renal angiomyolipoma in patients with tuberous sclerosis complex being treated for subependymal giant cell astrocytoma: subgroup results from the randomized, placebo-controlled, Phase 3 trial EXIST-1.Nephrol Dial Transplant · 201467 citationsRCR 2.5
- Quantitative and Mechanistic Understanding of AZD1775 Penetration across Human Blood-Brain Barrier in Glioblastoma Patients Using an IVIVE-PBPK Modeling Approach.Clin Cancer Res · 201759 citationsRCR 2.1
- A phase II study of dose-dense temozolomide and lapatinib for recurrent low-grade and anaplastic supratentorial, infratentorial, and spinal cord ependymoma.Neuro Oncol · 202152 citationsRCR 2.7
- 51 citationsRCR 2.4